News
Einhorn to Deliver Annual Meeting Keynote
Lawrence H. Einhorn, MD, a distinguished professor in the Indiana University School of Medicine Department of Medicine, will present a keynote at 1:45 pm central time on Sunday, October 20, during the 2024 AACI/CCAF Annual Meeting in Chicago.
Dr. Einhorn has been widely recognized for his success in medical oncology and in the development of a curative treatment for testicular cancer, the most common cancer in young men. His most recognized accomplishment is his development in 1974 of a chemotherapy regimen for disseminated testicular cancer that revolutionized the results of therapy and is responsible for a dramatic improvement in the cure rate of what previously had been a fatal disease. Dr. Einhorn's efforts and those of Dr. John P. Donohue, more than 95 percent of all patients with this disease who seek treatment at a major medical center now survive. This includes Dr. Einhorn's first patient, John Cleland, who passed away in 2022 – 48 years after his treatment.
Dr. Einhorn rose to greater prominence when he used his novel treatment paradigm to treat Lance Armstrong, cancer advocate and seven-time winner of the Tour de France. With Dr. Einhorn's treatment, Armstrong survived stage 3 testicular cancer, which initially presented with abdominal, brain and lung metastases.
He will highlight these and other accomplishments from his career, which spans over 50 years, during the keynote presentation.